Style | Citing Format |
---|---|
MLA | Karami J, et al.. "Statin Therapy and Lipid Indices in Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Control Trials." Current Pharmaceutical Design, vol. 30, no. 5, 2024, pp. 362-376. |
APA | Karami J, Razi B, Imani D, Aslani S, Pakjoo M, Fasihi M, Mohammadi K, Sahebkar A (2024). Statin Therapy and Lipid Indices in Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Control Trials. Current Pharmaceutical Design, 30(5), 362-376. |
Chicago | Karami J, Razi B, Imani D, Aslani S, Pakjoo M, Fasihi M, Mohammadi K, Sahebkar A. "Statin Therapy and Lipid Indices in Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Control Trials." Current Pharmaceutical Design 30, no. 5 (2024): 362-376. |
Harvard | Karami J et al. (2024) 'Statin Therapy and Lipid Indices in Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Control Trials', Current Pharmaceutical Design, 30(5), pp. 362-376. |
Vancouver | Karami J, Razi B, Imani D, Aslani S, Pakjoo M, Fasihi M, et al.. Statin Therapy and Lipid Indices in Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Control Trials. Current Pharmaceutical Design. 2024;30(5):362-376. |
BibTex | @article{ author = {Karami J and Razi B and Imani D and Aslani S and Pakjoo M and Fasihi M and Mohammadi K and Sahebkar A}, title = {Statin Therapy and Lipid Indices in Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Control Trials}, journal = {Current Pharmaceutical Design}, volume = {30}, number = {5}, pages = {362-376}, year = {2024} } |
RIS | TY - JOUR AU - Karami J AU - Razi B AU - Imani D AU - Aslani S AU - Pakjoo M AU - Fasihi M AU - Mohammadi K AU - Sahebkar A TI - Statin Therapy and Lipid Indices in Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Control Trials JO - Current Pharmaceutical Design VL - 30 IS - 5 SP - 362 EP - 376 PY - 2024 ER - |